NCT03667430View on ClinicalTrials.gov

Safety Evaluation of Porous Silica in Men

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

February 1, 2016

Study Completion Date

February 1, 2016

Conditions
Safety Issues
Interventions
DIETARY_SUPPLEMENT

Porous silica

The particle is rod shaped and approximately 1-3 x 0.4-0.5 micrometers with pore sizes in the range of 70-130 Ångström or 7-13 nanometer.

DIETARY_SUPPLEMENT

Placebo (microcrystalline cellulose)

All participants starts with five days placebo run in period

All Listed Sponsors
collaborator

Sigrid Therapeutics AB, Sweden

INDUSTRY

collaborator

Stockholm University

OTHER

lead

Karolinska Institutet

OTHER

NCT03667430 - Safety Evaluation of Porous Silica in Men | Biotech Hunter | Biotech Hunter